Company Profile

Kangpu Biopharmaceuticals, Ltd. is a clinical-stage company focused on the discovery and development of innovative small molecules for the treatment of solid tumors, hematologic malignancies, autoimmune diseases, and inflammatory disorders through novel solutions, including targeted protein ubiquitination and degradation.

Learn More

Research & Development

  • Technology

    Altering Substrate Specificity of the CRBN-E3 Ubiquitin Ligase Complex CRL4CRBN

  • Pipeline

    Kangpu Biopharmaceutical’s R&D program is exclusively focused on the discovery and development of novel and effective therapies that address significant unmet medical needs worldwide.

  • Clinical Trials

    Learn More
  • Diseases

    Learn More